Precigen (PGEN) Operating Margin (2012 - 2026)
Precigen's (PGEN) quarterly Operating Margin came in at 25.78% in Q1 2026, up 165923.0% year-on-year from N/an in Q1 2025, and up 90.64% on a QoQ basis from 275.44% in Q4 2025.
Precigen (PGEN) Operating Margin (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Operating Margin data on file, last reported at 25.78% in Q1 2026.
- On a quarterly basis, Operating Margin rose 165923.0% year-over-year to 25.78% in Q1 2026; TTM through Mar 2026 was 285.94%, a 203125.0% increase from a year earlier, with the FY2025 full-year figure at 1141.13%, up 229910.0% from the prior year.
- Operating Margin for Q1 2026 stood at 25.78%, up from 275.44% in the prior quarter.
- Over the last five years, Operating Margin for PGEN reached as high as 149.86% in Q4 2022 and fell as low as 2126200.0% in Q3 2024.
- Historically, Operating Margin has averaged 265392.52% across 5 years, with a median of 1440.13% in 2025.
- Across the five-year window, Operating Margin sank 209364793 bps in 2023 and jumped 212253960 bps in 2025, its largest moves.
- Year by year, Operating Margin stood at 149.86% in 2022, then slumped by 1960 bps to 2786.97% in 2023, then soared by 72 bps to 772.79% in 2024, then surged by 64 bps to 275.44% in 2025, then soared by 91 bps to 25.78% in 2026.
- Per Business Quant data, the three most recent Operating Margin figures were 25.78% in Q1 2026, 275.44% in Q4 2025, and 3660.4% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | -25.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.78% |
| Dec 31, 2025 | -275.44% |
| Sep 30, 2025 | -3,660.40% |
| Jun 30, 2025 | -4,067.09% |
| Mar 31, 2025 | -1,685.01% |
| Dec 31, 2024 | -772.79% |
| Sep 30, 2024 | -2,126,200.00% |
| Jun 30, 2024 | -8,485.50% |
| Mar 31, 2024 | -2,292.02% |
| Dec 31, 2023 | -2,786.97% |
| Sep 30, 2023 | -2,093,700.00% |
| Jun 30, 2023 | -1,195.25% |
| Dec 31, 2022 | 149.86% |
| Sep 30, 2022 | -52.07% |
| Jun 30, 2022 | -830.02% |
| Mar 31, 2022 | -401.83% |
| Dec 31, 2021 | 217.05% |
| Sep 30, 2021 | -645.96% |
| Jun 30, 2021 | -687.18% |
| Mar 31, 2021 | -72.16% |